Close Menu
CryptoHoppers.comCryptoHoppers.com
    What's Hot

    BTG Pactual Acquires Orama DTVM in Deal Valued at $99M

    October 3, 2023

    Revolutionizing Art Authentication: T.R.A.C.E. Technology by Transient Labs | NFT CULTURE | NFT News | Web3 Culture

    February 5, 2024

    Ripple (XRP) and Rexas Finance (RXS) Are Set for huge returns in 2025. Will They Outperform Ethereum (ETH)?

    April 5, 2025
    Facebook X (Twitter) Instagram
    • Privacy Policy
    • Get In Touch
    Facebook X (Twitter) Instagram
    CryptoHoppers.comCryptoHoppers.com
    • News

      Circle to Launch Cross-Chain Transfer Protocol V2 on Stellar: XLM Surges

      September 18, 2025

      China’s Biggest Bitcoin Treasury Firm Plans $500M Stock Sale To Buy More Crypto

      September 17, 2025

      Kart Rumble eyes $200k milestone as early momentum builds

      September 15, 2025

      Bitcoin Knots Tightens Grip, Snags Over a Quarter of Network Nodes

      September 14, 2025

      XRP Price At $23, Dogecoin To $2, And Solana At $1,800? Analyst Unveils 2026 Predictions

      September 13, 2025
    • Technology

      DeFi Development Corp. expands Solana treasury accelerator

      September 18, 2025

      Chainlink Teams Up with Taiko to Power Institutional-Grade DeFi on Ethereum

      September 17, 2025

      London Stock Exchange Launches Blockchain Platform for Private Funds

      September 16, 2025

      Dogecoin’s next big move – Will the price slingshot to $1.58?

      September 15, 2025

      Bullish patterns in Trump Coin face whale-sized risks

      September 14, 2025
    • Learn/Guide

      U.S. Government now holds more Bitcoin than China and the UK

      September 18, 2025

      Nakamoto set to acquire BTC Inc following successful audit

      September 17, 2025

      Chainlink joins AethirCloud’s AI Unbundled Alliance to support Web3 AI infrastructure

      September 16, 2025

      Base launches Solana bridge

      September 15, 2025

      Prenetics now holds 228 BTC and buys 1 BTC daily

      September 14, 2025
    • NFTs

      Slimesunday’s Magnum Opus: ‘Banned from New York’ Blows the Lid Off Digital Censorship | NFT CULTURE | NFT News | Web3 Culture

      July 22, 2025

      1mouth Analog: miirror’s Raw Leap from Digital to Handmade Chaos | NFT CULTURE | NFT News | Web3 Culture

      May 9, 2025

      NFTCulture Expands Into TCGs with Cardcore.xyz: Where Digital Collectibles Meet Competitive Play | NFT CULTURE | NFT News | Web3 Culture

      May 8, 2025

      From Moonshots to Broken Links: The Rise and Fall of CloneX | NFT CULTURE | NFT News | Web3 Culture

      April 24, 2025

      Pacific Spirit: Vinyl Meets Code in a Groundbreaking Generative Drop on Art Blocks | NFT CULTURE | NFT News | Web3 Culture

      April 16, 2025
    • Regulation

      FCA to Ease Rules for UK Crypto Firms While Tightening Cybersecurity Oversight

      September 18, 2025

      Bullish Secures New York BitLicense, Opens Door to U.S. Crypto Trading

      September 17, 2025

      UNDP Bets on Blockchain Education as Government Academy Prepares for 2025 Launch

      September 16, 2025

      Why India Won’t Legalise Full Crypto Laws Yet

      September 15, 2025

      Why the GENIUS Act, Not State Licenses, Could Decide Hyperliquid’s USDH Future

      September 14, 2025
    • Business

      Metaplanet Is About to Drop $881M Into Bitcoin, Here’s the Timeline

      August 27, 2025

      Sri Lanka’s E-commerce Platform Kapruka to Introduce Crypto Payments

      November 17, 2024

      Leading Eastern European Exchange Exmo Sells Business in Russia, Belarus

      November 16, 2024

      Bank of Russia to Launch Digital Ruble Payment Infrastructure by July 2025

      November 15, 2024

      Bitcoin Mining Company Mara Holdings Now Holds 26,747 Bitcoin: Q3 Earnings Report Reveals

      November 14, 2024
    • Live Pricing
    CryptoHoppers.comCryptoHoppers.com
    Home » 13 Best Healthcare Stocks to Buy in 2025
    News

    13 Best Healthcare Stocks to Buy in 2025

    February 14, 20258 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    13 Best Healthcare Stocks to Buy in 2025
    Share
    Facebook Twitter LinkedIn Pinterest Email



    There have been some major demand-side developments in the healthcare industry in recent years, most notably being driven by an aging global population, growth in the mental health awareness movement, and COVID-19. As a result, healthcare companies with established research and development processes and global supply chains have become a shrewd choice for investors.

    This article lists some of the best healthcare stocks to buy right now, placing a focus on each company’s specialization within the sector and discussing why the stocks could be a great pick.

    The best healthcare stocks to buy in 2025

    1. Lilly(Eli) & Co (LLY) – Leading in diabetes and obesity treatments with a strong pipeline
    2. Johnson & Johnson (JNJ) – Healthcare giant with pharmaceuticals, medical devices, and consumer health products
    3. Pfizer Inc. (PFE) – Known for vaccines and blockbuster drugs, focusing on innovation and expansion
    4. Merck & Co., Inc. (MRK) – Strong oncology and vaccine portfolio, including Keytruda
    5. Abbott Laboratories (ABT) – Specializes in diagnostics, medical devices, and nutrition products
    6. Gilead Sciences, Inc. (GILD) – Leader in antiviral treatments, including HIV and hepatitis drugs
    7. Amgen Inc. (AMGN) – Biotech pioneer focusing on innovative therapies for serious diseases
    8. Biogen Inc. (BIIB) – Focuses on neuroscience, including treatments for Alzheimer’s and multiple sclerosis
    9. Thermo Fisher Scientific Inc. (TMO) – Provides essential tools and services for biotech and pharma research
    10. UnitedHealth Group Incorporated (UNH) – Largest U.S. health insurer with strong healthcare services
    11. Medtronic plc (MDT) – Global leader in medical devices, specializing in cardiovascular and diabetes care
    12. AbbVie Inc (ABBV) – Known for immunology and oncology drugs, including Humira and Rinvoq
    13. Bristol Myers Squibb Company (BMY) – Focuses on oncology, immunology, and cardiovascular treatments

    Ranking the best healthcare companies for investors in 2025

    This section will cover each of the top 13 healthcare stocks to buy, their specializations, and why they represent a good pick in 2025. Let’s dive right in.

    1. Lilly(Eli) & Co (LLY)

    Eli Lilly & Co is a leader in diabetes and obesity treatments, with top-selling drugs like Mounjaro and Trulicity. The company’s strong R&D pipeline extends into oncology, immunology, and neuroscience, positioning it for continued growth. As global healthcare demand rises, LLY remains a strong long-term investment choice.

    Buy Lilly(Eli) & Co Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Lilly(Eli) & Co guide.

    2. Johnson & Johnson (JNJ)

    Johnson & Johnson is a well-established multinational corporation with a strong presence in the healthcare sector. The company is known for its consumer products that span healthcare and cosmetics, and it has built a strong reputation as a trusted brand as a result.

    Additionally, Johnson & Johnson is a leader in pharmaceutical innovation and invests heavily in the research and development of new drugs. JNJ stock provides good dividends, which could help boost investment returns by providing consistent income to shareholders on a quarterly basis.

    Buy Johnson & Johnson Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Johnson & Johnson guide.

    3. Pfizer Inc. (PFE)

    Pfizer pierced public consciousness by developing a globally promoted vaccine for COVID-19, owing to the company’s advanced pharmaceutical research and development processes. A key benefit of buying PFE stock is that the company provides good dividends to shareholders on a quarterly basis.

    Buy Pfizer Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Pfizer guide.

    4. Merck & Co., Inc. (MRK)

    Merck & Co is known for its contributions to medical science and breakthrough therapies, placing a focus on immuno-oncology at the core of its research and development practices. It has a very good reputation in terms of medical ethics and has an extensive portfolio of widely used vaccines for illnesses such as measles, mumps, and rubella.

    Buy Merck & Co Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Merck & Co guide.

    5. Abbott Laboratories (ABT)

    Abbott Laboratories is a diversified healthcare company with a range of products and services. The company operates in diagnostics, medical devices, nutrition, and established pharmaceuticals, and is particularly well known for its development of breakthrough diagnostics technologies.

    Buy Abbott Laboratories Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Abbott Laboratories guide.

    6. Gilead Sciences, Inc. (GILD)

    Gilead Sciences is a biopharmaceutical company known for its focus on developing and commercializing innovative therapies, particularly in the areas of antiviral drugs and liver diseases. Gilead gained attention during the COVID-19 pandemic for its antiviral drug remdesivir, which received Emergency Use Authorization (EUA) for the treatment of the virus.

    Buy Gilead Sciences Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Gilead Sciences guide.

    7. Amgen Inc. (AMGN)

    Amgen is renowned for its innovative work in biotechnology, particularly in the development of biologic drugs. Biologics are often used to treat complex diseases, and Amgen’s industry-leading research and development in the field have given it tremendous value within the global healthcare industry.

    Buy Amgen Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Amgen guide.

    8. Biogen Inc. (BIIB)

    Biogen is a biotechnology company known for its focus on developing therapies for neurological and neurodegenerative diseases. Due to the aging population in western markets, Biogen could represent a shrewd investment over the coming decades as neurodegenerative diseases are particularly common in older demographics.

    Buy Biogen Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Biogen guide.

    9. Thermo Fisher Scientific Inc. (TMO)

    Thermo Fisher Scientific is a leading life sciences company known for its broad range of products and services in the fields of scientific research, healthcare, and diagnostics. The company provided diagnostic tests, laboratory equipment, and other critical supplies to support COVID-19 testing and research, which led to price appreciation for TMO stock.

    Buy Thermo Fisher Scientific Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Thermo Fisher Scientific guide.

    10. UnitedHealth Group Incorporated (UNH)

    UnitedHealth Group is a diversified healthcare company and one of the largest health insurers in the United States. The U.S. healthcare industry operates differently from many other first-world countries, in that healthcare is not supplied as a public good but rather it’s a fully private industry in which insurance plays an important role for affordability. As a result, UnitedHealth looks set to remain an important player in the sector and could be a great investment.

    Buy UnitedHealth Group Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in UnitedHealth Group guide.

    11. Medtronic plc (MDT)

    Medtronic is a global medical technology company that supplies a broad portfolio of medical devices to hospitals and other healthcare centers. Its technological research and development make the company stand out from other options on this list, as Medtronic has positioned itself within an important industry vertical as a well-trusted brand.

    Buy Medtronic Stock

    12. AbbVie Inc (ABBV)

    AbbVie is a pharmaceutical company known for its focus on research and development in various therapeutic areas. The company’s flagship product, Humira, is one of the most popular treatments for rheumatoid arthritis (RA) and has become a best-seller as a result. Additionally, ABBV stocks are known to provide consistently good dividends to shareholders.

    Buy AbbVie Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in AbbVie guide.

    13. Bristol Myers Squibb Company (BMY)

    Bristol Myers Squibb is a global pharmaceutical company with a focus on developing and commercializing innovative medicines. The company is a leader in oncology and has a healthy financial performance, and also invests in schemes to improve patient access and affordability for medical treatments around the world.

    Buy Bristol Myers Squibb Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Bristol Myers Squibb guide.

    The bottom line

    As a growing global industry that is in perpetual demand, healthcare stocks can be some of the most secure ways to protect and grow capital over the long term. Each of the companies on our list represents strong picks, but there are other options out there as well. From consumer products, to medical devices and technologies, to the research and development of new medicines, the most influential healthcare companies provide important services for people all over the world, and therefore represent a strong addition to any investment portfolio.

    If you want to invest in other fields as well, such as computing, check out our list of the best semiconductor stocks to buy.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Circle to Launch Cross-Chain Transfer Protocol V2 on Stellar: XLM Surges

    September 18, 2025

    China’s Biggest Bitcoin Treasury Firm Plans $500M Stock Sale To Buy More Crypto

    September 17, 2025

    Kart Rumble eyes $200k milestone as early momentum builds

    September 15, 2025

    Bitcoin Knots Tightens Grip, Snags Over a Quarter of Network Nodes

    September 14, 2025
    Top Posts

    Central Bank of Italy Raises Alarm on Bitcoin P2P Services

    December 26, 2024

    PayPal Makes A Game-Changing Leap Into Crypto, Launches PYUSD Stablecoin Powered by Paxos Trust

    August 8, 2023

    Robinhood turns profitable for the first time since going public

    August 3, 2023

    Welcome to CryptoHoppers.com! Stay informed with the latest updates, trends, and insights from the dynamic world of cryptocurrencies. From Bitcoin to altcoins, blockchain technology to decentralized finance (DeFi), we cover it all. Discover expert analysis, market trends, regulatory developments, and exciting innovations shaping the crypto industry.

    Top Insights

    Circle to Launch Cross-Chain Transfer Protocol V2 on Stellar: XLM Surges

    September 18, 2025

    China’s Biggest Bitcoin Treasury Firm Plans $500M Stock Sale To Buy More Crypto

    September 17, 2025

    Kart Rumble eyes $200k milestone as early momentum builds

    September 15, 2025
    Advertisement
    Demo
    CryptoHoppers.com
    Facebook X (Twitter) Instagram
    • News
    • Technology
    • Learn/Guide
    • Regulation
    • NFTs
    • Business
    • Live Pricing
    © 2025. Designed by CryptoHoppers.com.

    Type above and press Enter to search. Press Esc to cancel.